4-(2,4-difluorophenyl)-6,7-dimethylpteridine;4-[(2R)-oxan-2-yl]-1-(oxetan-3-yl)pyrazole
C25H26F2N6O2 — CID 166122277
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(2,4-difluorophenyl)-6,7-dimethylpteridine;4-[(2R)-oxan-2-yl]-1-(oxetan-3-yl)pyrazole
4-(2,4-difluorophenyl)-6,7-dimethylpteridine;4-[(2R)-oxan-2-yl]-1-(oxetan-3-yl)pyrazole (PubChem CID 166122277) has the molecular formula C25H26F2N6O2 and a molecular weight of 480.52 g/mol. Its IUPAC name is 4-(2,4-difluorophenyl)-6,7-dimethylpteridine;4-[(2R)-oxan-2-yl]-1-(oxetan-3-yl)pyrazole.
Molecular Properties
| Compound Name | 4-(2,4-difluorophenyl)-6,7-dimethylpteridine;4-[(2R)-oxan-2-yl]-1-(oxetan-3-yl)pyrazole |
|---|---|
| PubChem CID | 166122277 |
| Molecular Formula | C25H26F2N6O2 |
| Molecular Weight | 480.52 g/mol |
| Exact Mass | 480.21 |
| IUPAC Name | 4-(2,4-difluorophenyl)-6,7-dimethylpteridine;4-[(2R)-oxan-2-yl]-1-(oxetan-3-yl)pyrazole |
| SMILES | Cc1nc2ncnc(-c3ccc(F)cc3F)c2nc1C.c1nn(C2COC2)cc1[C@H]1CCCCO1 |
| InChI | InChI=1S/C14H10F2N4.C11H16N2O2/c1-7-8(2)20-14-13(19-7)12(17-6-18-14)10-4-3-9(15)5-11(10)16;1-2-4-15-11(3-1)9-5-12-13(6-9)10-7-14-8-10/h3-6H,1-2H3;5-6,10-11H,1-4,7-8H2/t;11-/m.1/s1 |
| InChIKey | FATPMQGLAFPRHE-HVZQFPCNSA-N |
| XLogP | 4.68 |
| TPSA | 87.84 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 480.52 |
| LogP ≤ 5 | 4.68 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166122277 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.